Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.05% to 8407.44, DAX +0.47% to 22064.51, CAC40 +0.27% to 7502.78, STOXX 600 +0.36% to 518.61

Apr 24 ,2025

  • Synopsis:

    • European equity markets ended in positive territory. Follows two consecutive gains, including a strong rally on Wednesday. In sectors, autos, tech and constructions the best performers while banks and telco main laggards.

    • Markets consolidating in Europe after recent gains. More signs of US-China tariff de-escalation after reports noted White House considering cutting China tariffs by more than 50%. Follows Trump's remarks day earlier flagging substantial tariff reduction. Situation remains fluid with Treasury Secretary Bessent saying tariffs would not fall unilaterally and that trade deal could take 2-3 years.

    • Meanwhile, the German government downgraded its economic growth forecast to zero citing the impact of US trade policies. On macro calendar, German Ifo business climate index beat expectations, French consumer confidence held steady while UK April CBI Industrial Trends Orders miss.

    • Amidst busy earnings calendar; of note, Sanofi reports Q1 EPS ahead of expectations and confirmed 2025 guidance; BNP Q1 net income was mostly in line with forecasts; Air Liquide Q1 revenues beat and gave a positive update; Orange Q1 earnings met consensus and confirmed targets for 2025; Roche Q1 revenue beat amid a 6% increase in group sales due to high demand for new medicines and diagnostic solutions; Nokia Q1 EPS a bit light of consensus, though confirmed guidance; Unilever Q1 trading update saw revenue miss, but underlying sales growth ahead of consensus and it reconfirmed outlook. Other earning reports included UPM-Kymmene. Anglo American, Inchcape. Metso.

    • In M&A news,Tarkett Participation increased offer price to €17 from €16 in its public buy-out offer of Tarkett.

    • Looking ahead to tomorrow's EU econ-calendar, notable releases will include, amongst others, UK Mar retail sales, Apr consumer confidence - Gfk and France Apr business confidence.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Autos & Parts +1.86%, Technology +1.06%, Construct & Mtls +1.04%, Basic Resources +0.99%, Media +0.96%, Chemicals +0.91%, Oil & Gas +0.86%, Ind Goods & Svcs +0.79%, Health Care +0.68%, Financial Svcs +0.65%, Real Estate +0.54%, Utilities +0.52%

      • Underperformers:

        • Banks (1.06%), Telecom (0.83%), Travel & Leisure (0.58%), Retail (0.58%), Insurance (0.30%), Food & Beverage +0.18%, Persnl & HHold Goods +0.32%

    • Macro:

      • Central Banks:

        • ECB's Lane Says Trade Fallout Is Unlikely to Cause Recession -- Bloomberg

        • ECB Must Be Agile and Shouldn't Rule Out Larger Cut, Rehn Says -- Bloomberg

        • BOE Must Assume Economic Shocks Will Persist, Lombardelli Says -- Bloomberg

      • EU/UK:

        • UK deal with EU will not return to 'arguments of the past', minister says -- Guardian

        • UK edges towards youth visa deal with EU -- BBC

      • Germany:

        • Germany downgrades 2025 growth forecast to zero -- FT

        • Why German beer is disappearing -- thedrinksbusiness

      • France:

        • Macron calls report on new snap elections 'complete nonsense' -- Politico

      • Italy:

        • Can Meloni Save the Transatlantic Alliance? -- carnagieeurope

        • Innovation Marks The Wines Of Italy's Northernmost Region, Alto Adige -- Forbes

    • Company news:

      • Notable Gainers

        • +22.5% SFR.LN (Severfield £0.23, +0.05) -- trading update

        • +16.9% VERK.FH (Verkkokauppa.com €2.42, +0.35) -- Q1 earnings

        • +16.8% NEWA.B.SS (New Wave Group SEK105.30, +15.50) -- Q1 earnings

        • +15.0% CINT.SS (Cint Group SEK7.46, +1.03) -- Q1 earnings

        • +14.5% PODP.LN (Pod Point Group Holdings £0.06, +0.01) -- receives non-biding conditional proposal from EDF; delays publication of FY results

        • +14.2% AOM.LN (Activeops £0.94, +0.12) -- trading update

        • +13.2% XFAB.FP (X-FAB Silicon Foundries €4.65, +0.56) -- Q1 earnings

        • +13.1% EAH.LN (Eco Animal Health Group £0.62, +0.07) -- trading update

        • +12.4% BEAN.SW (BELIMO Holding CHF590.50, +68.50) -- Q1 revenue

        • +11.7% GALD.SW (Galderma Group CHF86.15, +9.40) -- Q1 revenue

        • +11.4% BSL.GR (Basler €8.44, +0.92) -- Hauck & Aufhäuser upgrade

        • +11.1% INDV.LN (Indivior £7.70, +0.77) -- Q1 earnings

        • +8.1% IBT.B.SS (Infant Bacterial Therapeutics SEK53.00, +4.00) -- trial result presentation

        • +8.0% TNOM.FH (Talenom €3.42, +0.26) -- Q1 earnings

        • +7.3% SGG.SS (Sensys Gatso Group SEK43.70, +3.00) -- Q1 earnings

        • +7.0% METSO.FH (Metso Corp. €9.09, +0.62) -- Q1 earnings

        • +6.9% XVIVO.SS (Xvivo Perfusion SEK308.00, +20.20) -- Q1 earnings

        • +6.8% ORNBV.FH (Orion €52.55, +3.40) -- SEB and Carnegie Securities upgrades

        • +6.2% HNSA.SS (Hansa Biopharma SEK24.74, +1.38) -- Q1 earnings; new CEO

        • +6.2% BEIJ.B.SS (Beijer Ref SEK150.10, +8.70) -- Q1 earnings

        • +5.6% SNR.LN (Senior £1.23, +0.07) -- trading update

        • +5.6% SVIK.SS (Studsvik SEK129.00, +7.00) -- Q1 earnings

        • +5.6% BRCK.LN (Brickability Group £0.62, +0.03) -- trading update

        • +5.5% 8KW.GR (Jadestone Energy Plc €0.23, +0.01) -- concluded a number of actions to enhance its balance sheet

        • +5.5% IDL.FP (ID Logistics Group €381.50, +20.00) -- Q1 revenue

        • +5.3% STMPA.FP (STMicroelectronics €19.68, +1.01) -- Q1 earnings

        • +4.4% RNO.FP (Renault €46.14, +1.97) -- Q1 revenue

        • +3.4% AET.LN (Afentra £0.40, +0.01) -- FY earnings; new Chairman

        • +3.3% VAIAS.FH (Vaisala €45.30, +1.45) -- Q1 earnings

        • +2.8% NELLY.SS (Nelly Group SEK40.20, +1.09) -- Q1 earnings

        • +2.1% NIL.B.SS (Nilörngruppen SEK60.00, +1.20) -- Q1 earnings

        • +2.0% AFK.NO (Arendals Fossekompani NOK126.00, +2.50) -- Pareto upgrade

      • Notable Decliners

        • -44.4% RWS.LN (RWS Holdings £0.76, -0.51) -- trading update

        • -29.9% PRIC.B.SS (Pricer SEK5.92, -2.50) -- Q1 earnings

        • -28.8% AUTO.NO (AutoStore Holdings NOK5.37, -2.19) -- Q1 earnings;Arctic Securities downgrade

        • -20.8% FLOW.NA (Flow Traders €24.28, -6.30) -- Q1 earnings; CEO to step down

        • -19.2% QTCOM.FH (Qt Group €58.80, -13.55) -- Q1 earnings

        • -18.6% ENEA.SS (Enea AB SEK67.00, -14.70) -- Q1 earnings

        • -16.3% SOM.LN (Somero Enterprises £2.05, -0.40) -- trading update

        • -15.8% DETEC.FH (Detection Technology €11.80, -2.05) -- Q1 earnings

        • -15.4% AZE.BB (Azelis Group €13.18, -2.39) -- Q1 earnings

        • -14.2% GBG.LN (GB Group £2.31, -0.38) -- trading update

        • -11.7% ORY.SM (Oryzon Genomics €2.87, -0.37) -- raises €30M in capital increase through the issuance of 12.8M new shares priced at €2.35/sh

        • -11.4% WLN.FP (Worldline €5.20, -0.65) -- Q1 revenue

        • -9.5% NOKIA.FH (Nokia €4.28, -0.44) -- Q1 earnings

        • -9.3% IMCD.NA (IMCD €114.75, -11.40) -- CEO to step down

        • -8.4% SECARE.SS (Swedencare SEK34.75, -3.10) -- Q1 earnings

        • -8.4% PCELL.SS (PowerCell Sweden SEK27.02, -2.40) -- Q1 earnings

        • -7.7% MIPS.SS (MIPS SEK338.00, -28.00) -- Q1 earnings

        • -7.6% VITR.SS (Vitrolife SEK147.20, -11.90) -- Q1 earnings

        • -6.8% INCH.LN (Inchcape £6.30, -0.47) -- trading update

        • -6.6% LUMEN.SS (LumenRadio SEK63.00, -4.40) -- Q1 earnings

        • -5.1% DSY.FP (Dassault Systemes €31.68, -1.73) -- Q1 earnings

        • -5.0% ALIG.SS (Alimak Group SEK115.20, -6.00) -- Q1 earnings

        • -4.1% NOTE.SS (NOTE SEK165.90, -7.30) -- Q1 earnings

        • -3.8% HO.FP (Thales €239.70, -9.50) -- Q1 revenue

        • -3.6% BACTI.B.SS (Bactiguard Holding SEK29.40, -1.10) -- Q1 earnings

        • -3.3% VU.FP (VusionGroup €196.00, -6.80) -- Q1 earnings

        • -3.2% VONN.SW (Vontobel Holding CHF56.30, -1.90) -- trading update

        • -2.7% HUSQ.B.SS (Husqvarna SEK44.30, -1.28) -- Q1 earnings; CEO to step down

        • -2.2% VOS.GR (Vossloh €63.70, -1.50) -- Q1 earnings

        • -2.0% AWE.LN (Alphawave IP Group £1.10, -0.02) -- trading update

        • -1.9% SFAB.SS (Solid Försäkring SEK83.40, -1.60) -- Q1 earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • Austria: Palfinger (PAL.AV)

        • Benelux: Warehouses De Pauw (WDP.BB), Cofinimmo (COFB.BB), Signify (LIGHT.NA)

        • Finland: Wartsila (WRT1V.FH), Stora Enso (STERV.FH), Kemira (KEMIRA.FH), Terveystalo (TTALO.FH), Alma Media (ALMA.FH), Kempower (KEMPOWR.FH), Enento Group (ENENTO.FH), WithSecure Corp. (WITH.FH), Lemonsoft (LEMON.FH), Apetit (APETIT.FH), Consti (CONSTI.FH)

        • Germany: Nordex (NDX1.GR)

        • Norway: Yara International (YAR.NO), Hoegh Autoliners (HAUTO.NO), Magnora (MGN.NO), Vistin Pharma (VISTN.NO)

        • Southern Europe: Mapfre (MAP.SM)

        • Sweden: Saab (SAAB.B.SS), Lifco (LIFCO.B.SS), Indutrade (INDT.SS), Svenska Cellulosa (SCA.B.SS), SKF (SKF.B.SS), Mycronic (MYCR.SS), Hemnet Group (HEM.SS), HEXPOL (HPOL.B.SS),AddLife AB (ALIF.B.SS), Bufab (BUFAB.SS), Addnode Group (ANOD.B.SS), Granges (GRNG.SS), Bilia (BILI.A.SS), Beijer Alma (BEIA.B.SS), NCAB Group (NCAB.SS), Nederman Holding (NMAN.SS), Boozt (BOOZT.SS), Alligo (ALLIGO.B.SS), Duni (DUNI.SS), BHG Group (BHG.SS), CTT Systems (CTT.SS), Cavotec (CCC.SS), Midsona (MSON.B.SS), Doro (DORO.SS)

        • Switzerland: BB Biotech (BION.SW), Xlife Sciences (XLS.SW)

      • Trading Update:

        • Benelux: IMCD (IMCD.NA), Koninklijke Heijmans (HEIJM.NA), ACOMO (ACOMO.NA)

        • Finland: Digia (DIGIA.FH)

        • France: Safran (SAF.FP), SPIE (SPIE.FP), Lagardere (MMB.FP), Seche Environnement (SCHP.FP), Sword Group (SWP.FP)

        • Southern Europe: Distribuidora Internacional De Alimentacion (DIA.SM)

        • Switzerland: Holcim Ltd. (HOLN.SW)

        • UK: WPP (WPP.LN)

  • Data:

    • Economics:

      • UK Apr CBI Industrial Trends Orders (26) vs consensus (36) and prior (29)

      • Germany Apr IFO Business Climate 86.9 vs consensus 85.1 and prior 86.7

        • Current Conditions 86.4 vs consensus 85.5 and prior 85.7

        • Expectations 87.4 vs consensus 85.0 vs prior 87.7

      • France Apr Consumer Confidence 92 vs consensus 91 and prior 92

      • Spain Mar PPI +4.9% y/y vs consensus +3.2% and prior +6.6%

      • Finland Mar Unemployment Rate 10.1% vs consensus 9.9% and prior 9.4%

    • Markets:

      • WTI Crude (25-Jun): ($0.01) or (0.02%) to $62.26

      • €-$ +0.0038 or +0.34% to 1.1353

      • £-$ +0.0040 or +0.30% to 1.3295

      • €-£ +0.0004 to 0.8540

      • S&P 500 +1.31%

      • Performance year-to-date:

        • FTSE 100: +2.87%

        • DAX: +10.83%

        • CAC: +1.65%

        • MIB: +7.67%

        • Stoxx 600: +2.17%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE